Article highlights FDA approval of OTC daily oral contraceptives, emphasizing their importance for reproductive health access.
In July 2023, the US Food and Drug Administration approved the first over-the-counter (OTC) daily oral contraceptive pill, Opill (norgestrel). The widespread availability of a daily oral contraceptive pill without a prescription is a major advancement in reproductive health and improves access to safe, effective, affordable contraception. This article outlines the types of OTC contraceptives currently available in the United States, with a focus on OTC norgestrel and its implications for increased accessibility to reproductive healthcare.
No takes yet. Share an insight, caveat, or question.
Takalkar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: